Exploring bacterial metabolites in microbe-human host dialogue and their therapeutic potential in Alzheimer's diseases

被引:1
作者
Singh, Sarangthem Dinamani [1 ,3 ]
Bharali, Pankaj [2 ,3 ]
Nagamani, Selvaraman [1 ,3 ]
机构
[1] CSIR North East Inst Sci & Technol CSIR NEIST, Adv Computat & Data Sci Div, Jorhat 785006, India
[2] CSIR North East Inst Sci & Technol CSIR NEIST, Ctr Infect Dis, Biol Sci & Technol Div, Jorhat 785006, Assam, India
[3] Acad Sci & Innovat Res AcSIR, Ghaziabad 201002, India
关键词
Alzheimer's disease; Microbiota signaling target metabolites network analysis; Gut microbiota; Molecular docking; GUT MICROBIOTA; TARGET; GSK3; PHARMACOLOGY; PLATFORM; DATABASE; GENES;
D O I
10.1007/s11030-024-11028-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurological dysfunction in association with aging, dementia, and cognitive impairment is the major cause of Alzheimer's disease (AD). Current AD therapies often yield unsatisfactory results due to their poor mechanism in treating the underlying mechanism of the disease. Recent studies suggested that metabolites from the gut microbiota facilitate brain-gut communication. A systematic network pharmacology study and the structure- and analog-based approaches are employed to investigate the metabolites produced by gut microbiota to treat AD. The microbiota metabolites available in the gutMGene database were considered in this study. Two servers, namely Swiss Target Prediction (STP) and Similarity Ensemble Approach (SEA), were used to identify the possible AD targets for the selected metabolites. Detailed KEGG pathway and Gene Ontology (GO) analysis on identified hub genes highlighted the importance of IL6, AKT1, and GSK3B in AD pathophysiology. MMTSp (Microbiota Metabolites Target Signaling pathways) network analysis elucidated that there is a strong relationship with microbiota (Paraprevotella xylaniphila YIT 11841, Bifidobacterium dentium, Paraprevotella clara YIT 11840, Enterococcus sp. 45, Bacteroides sp. 45, Bacillus sp. 46, Escherichia sp. 33, Enterococcus casseliflavus, Bacteroides uniformis, Alistipes indistinctus YIT 12060, Bacteroides ovatus, Escherichia sp. 12, and Odoribacter laneus YIT 12061) and AD pathogenesis. In addition to this, we performed molecular docking to study the metabolite interactions in the AD drug targets. The ADME/T properties of these metabolites were also calculated and the results are discussed in detail.
引用
收藏
页数:17
相关论文
共 43 条
[41]   An overview on therapeutic and medicinal potential of poly-hydroxy flavone viz. Heptamethoxyflavone, Kaempferitrin, Vitexin and Amentoflavone for management of Alzheimer's and Parkinson's diseases: a critical analysis on mechanistic insight [J].
Varshney, Mansi ;
Kumar, Bhavna ;
Rana, Vijay Singh ;
Sethiya, Neeraj K. .
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2023, 63 (16) :2749-2772
[42]   Unraveling the therapeutic potential of ginsenoside compound Mc1 in Alzheimer's disease: Exploring the role of AMPK/SIRT1/NF-κB signaling pathway and mitochondrial function [J].
Yuan, Qi ;
Yang, Zhaokun .
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 33 (10) :1105-1114
[43]   Exploring the Therapeutic Potential of BBB-Penetrating Phytochemicals With p38 MAPK Modulatory Activity in Addressing Oxidative Stress-Induced Neurodegenerative Disorders, With a Focus on Alzheimer's Disease [J].
Hosseini, Asieh ;
Sheibani, Mohammad ;
Valipour, Mehdi .
PHYTOTHERAPY RESEARCH, 2024, 38 (12) :5598-5625